Click on image to view larger version.

Figure 3 Six-month rates of death, nonfatal myocardial infarction or need for revascularization (coronary artery bypass surgery or percutaneous intervention) among the three randomized groups. Most of the events occurred early, and hormone therapy did not reduce the adverse event rate, p = 0.98. E = conjugated equine estrogen; MPA = medroxyprogesterone; PLBO = placebo.